Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-08-09 | 163930 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-08-20 | 163933 |
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-12-08 | 163948 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2022-06-30 | 2022-10-18 | 163954 |
| TEVA-RISEDRONATE | 150MG | TABLET | Resolved | 2022-06-30 | 2024-02-06 | 163957 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2022-07-25 | 2023-04-28 | 165430 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-07-25 | 2023-04-28 | 165433 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165436 |
| TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2022-07-25 | 2022-10-01 | 165441 |
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165444 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2022-07-25 | 2022-09-23 | 165450 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2022-07-25 | 2023-01-19 | 165453 |
| TEVA-FEBUXOSTAT | 80MG | TABLET | Resolved | 2022-07-25 | 2023-01-12 | 165456 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-08-18 | 2022-10-18 | 167153 |
| ALERTEC | 100MG | TABLET | Resolved | 2022-08-18 | 2022-09-23 | 167165 |
| TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167168 |
| TEVA-HALOPERIDOL | 10MG | TABLET | Resolved | 2022-08-18 | 2023-06-09 | 167171 |
| TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167174 |
| TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167177 |
| TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167179 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Discontinued | 2019-04-11 | 2019-04-11 | 81353 |